Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT05907447Unknown

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Role: collaborator

NCT04150835Phase 4Unknown

Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Role: collaborator

NCT01293734Phase 2Completed

Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.

Role: collaborator

All 5 trials loaded